1. Metal-dependent Deacetylases: Cancer and Epigenetic Regulators
   Jeffrey E. López et al, 2016, ACS Chemical Biology CrossRef
2. Impact of Epigenetic Alterations in the Development of Oral Diseases
   Rodopi Emfietzoglou et al, 2021, Current Medicinal Chemistry CrossRef
3. Epigenetic Regulations of Perineural Invasion in Head and Neck Squamous Cell Carcinoma
   Pavel Hurník et al, 2022, Frontiers in Genetics CrossRef
4. Histone Deacetylase Inhibitors as Therapeutic Interventions on Cervical Cancer Induced by Human Papillomavirus
   Natália Lourenço de Freitas et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
5. Synthesis, Biochemical, and Cellular Evaluation of HDAC6 Targeting Proteolysis Targeting Chimeras
   Salma Darwish et al, 2023, HDAC/HAT Function Assessment and Inhibitor Development CrossRef
6. Zinc Dependent Histone Deacetylase Inhibitors in Cancer Therapeutics: Recent Update
   Faria Sultana et al, 2020, Current Medicinal Chemistry CrossRef
7. Spiroindoline-Capped Selective HDAC6 Inhibitors: Design, Synthesis, Structural Analysis, and Biological Evaluation
   A. Prasanth Saraswati et al, 2020, ACS Medicinal Chemistry Letters CrossRef
8. A Histone Deacetylase Inhibitor Manifests Synergistic Interaction with Artesunate by Suppressing DNA Repair Activity
   Asif Raza et al, 2022, Sci CrossRef
9. Cytotoxicity Mediated by Histone Deacetylase Inhibitors in Cancer Cells: Mechanisms and Potential Clinical Implications
   David S. Schrump, 2009, Clinical Cancer Research CrossRef
10. Epigenetic Modifications in Head and Neck Cancer
    Jadwiga Gaździcka et al, 2020, Biochemical Genetics CrossRef
11. Integrative analysis of lysine acetylation-related genes and identification of a novel prognostic model for oral squamous cell carcinoma
    Shi-Zhou Deng et al, 2023, Frontiers in Molecular Biosciences CrossRef
12. Ubiquitin Proteasome System Stress Underlies Synergistic Killing of Ovarian Cancer Cells by Bortezomib and a Novel HDAC6 Inhibitor
    Martina Bazzaro et al, 2008, Clinical Cancer Research CrossRef
13. Exploration of the binding pocket of histone deacetylases: the design of potent and isoform-selective inhibitors
    Abdullahi İbrahim UBA et al, 2017, TURKISH JOURNAL OF BIOLOGY CrossRef
14. Advances in the Histone Acetylation Modification in the Oral Squamous Cell Carcinoma
    Ying Lu et al, 2023, Journal of Oncology CrossRef
15. Structural Requirements of HDAC Inhibitors: SAHA Analogues Modified at the C2 Position Display HDAC6/8 Selectivity
    Ahmed T. Negmeldin et al, 2017, ACS Medicinal Chemistry Letters CrossRef
16. Isoflurane promotes proliferation of squamous cervical cancer cells through mTOR-histone deacetylase 6 pathway
    Wenwen Zhang et al, 2021, Molecular and Cellular Biochemistry CrossRef
17. The Cytoplasmic Deacetylase HDAC6 Is Required for Efficient Oncogenic Tumorigenesis
    Yi-Shan Lee et al, 2008, Cancer Research CrossRef
18. Histone Deacetylases and Their Potential as Targets to Enhance Tumour Radiosensitisation
    Jennifer Antrobus et al, 2022, Radiation CrossRef